Abstract
The genetic tyrosinemias, autosomal recessive disorders, are characterized by the accumulation of tyrosine in body fluids and tissues. There are three types of tyrosinemias: Types I, II, and III. Type I has a prevalence of about 1 in 100,000 newborns in the general population. Type III is extremely rare (Fig. 1).
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Danks, D. M., Tippett, P., & Rogers, J. (1975). A new form of prolonged transient tyrosinemia presenting with severe metabolic acidosis. Acta Paediatrica Scandinavica, 64, 209–221.
De Laet, C., Dionisi-Vici, C., Leonard, J. V., et al. (2013). Recommendations for the management of tyrosinemia type 1. Orphanet Journal of Rare Diseases, 8, 8–16.
Goldsmith, L. A., Kang, E., Bienfang, D. C., et al. (1973). Tyrosinemia with plantar and palmar keratosis and keratitis. Journal of Pediatrics, 83, 798–805.
Huhn, R., Stoermer, H., Klingele, B., et al. (1998). Novel and recurrent tyrosine aminotransferase gene mutations in tyrosinemia Type II. Human Genetics, 102, 305–313.
King, L. S., Trahms, C., & Scott, C. R. (2014). Tyrosinemia type I. GeneReviews, 17, 2014.
Lindblad, B., Lindstedt, S., & Steen, G. (1977). On the enzymic defects in hereditary tyrosinemia. Proceedings of the National Academy of Sciences of the United States of America, 74, 4641–4645.
Macsai, M. S., Schwartz, T. L., Hinkle, D., et al. (2001). Tyrosinemia type II: Nine cases of ocular signs and symptoms. American Journal of Ophthalmology, 132, 522–527.
Mitchell, G. A., Grompe, M., Lambert, M., & Tanguay, R. M. (2001). Hypertyrosinemia. In C. R. Scriver, A. Beaudet, W. Sly, & D. Valle (Eds.), The metabolic and molecular bases of inherited disease (pp. 1777–1805). New York: McGraw-Hill.
Rafati, M., Mohamadhashem, F., Hoseini, A., et al. (2016). Prenatal diagnosis of tyrosinemia type 1 using next generation sequencing. Fetal and Pediatric Pathology, 35, 282–285.
Rehak, A., Selim, M. M., & Yadav, G. (1981). Richner–Hanhart syndrome (tyrosinaemia-II) (report of four cases without ocular involvement). British Journal of Dermatology, 104, 469–475.
Roth, K. S., Carter, B. E., & Higgins, E. S. (1991). Succinylacetone effects on renal tubular phosphate metabolism: A model for experimental renal Fanconi syndrome. Proceedings of the Society for Experimental Biology and Medicine, 196, 428–431.
Scott, C. R. (2006). The genetic tyrosinemias. American Journal of Medical Genetics Part C (Seminars in Medical Genetics), 142C, 121–126.
Tomoeda, K., Awata, H., Matsuura, T., et al. (2000). Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene are responsible for tyrosinemia type III and hawkinsinuria. Molecular Genetics and Metabolism, 71, 506–510.
van Spronsen, F. J., Thomasse, Y., Smit, G. P., et al. (1994). Hereditary tyrosinemia type I: A new clinical classification with difference in prognosis on dietary treatment. Hepatology, 20, 1187–1191.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this entry
Cite this entry
Chen, H. (2017). Tyrosinemias. In: Atlas of Genetic Diagnosis and Counseling. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2401-1_279
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2401-1_279
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-2400-4
Online ISBN: 978-1-4939-2401-1
eBook Packages: MedicineReference Module Medicine